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Diabetes distress in Indonesian patients
with type 2 diabetes: a comparison
between primary and tertiary care
Bustanul Arifin1,2,3,4* , Antoinette D. I. van Asselt1,4,5, Didik Setiawan6, Jarir Atthobari7,8,
Maarten J. Postma1,3,4,9,10 and Qi Cao1
Abstract
Background: The number of people living with diabetes mellitus (DM) in Indonesia has continued to increase over
the last 6 years. Four previous studies in U.S have found that higher DD scores were associated with worse
psychological outcomes, lower health-related quality of life (HRQoL) and increased risk of T2DM complications. In
this study, we aimed to firstly compare DD scores in Indonesian T2DM outpatients treated in primary care versus
those in tertiary care. Subsequently, we investigated whether socio-demographic characteristics and clinical conditions
explain potential differences in DD score across healthcare settings.
Methods: A cross-sectional study was conducted on Java island in three primary care (n = 108) and four tertiary care
(n = 524) facilities. The participants completed the Bahasa Indonesia version of the Diabetes Distress Scale questionnaire
(DDS17 Bahasa Indonesia). Ordinal regression analysis was conducted with the quartile of the summation of the DD
score as the dependent variable to investigate how the association between the level of healthcare facilities and DD
altered when adding different variables in the model.
Results: The final adjusted model showed that the level of healthcare facilities was strongly associated with DD
(p < .001), with participants in primary care having a 3.68 times (95% CI 2.46–5.55) higher likelihood of being more
distressed than the participants in tertiary care. This association was detected after including the socio-demographic
characteristics and clinical conditions as model confounders.
Conclusions: This is the first study in Indonesia to compare DD scores within different healthcare facilities. We
recommend a regular DD assessment, possibly closely aligned with health-literacy partner programs, especially for
T2DM patients in primary care settings.
Keywords: Diabetes distress, Indonesia, Primary care, Tertiary care
Background
The number of people living with diabetes mellitus
(DM) in Indonesia has continued to increase over the
last 6 years. In 2009, the International Diabetes
Federation (IDF) estimated that there were around 7.3
million people living with type 2 DM (T2DM) and in
2017 this number increased to 10.3 million, among
whom 7.3 million are undiagnosed [1, 2]. The percent-
age of persons living with T2DM was higher in females
than in males (7.7% vs. 5.6%), and new cases were not
only found in the above-55-years age group but also in
younger age groups (starting at 15 years of age). With re-
gard to the level of education, the highest prevalence
was found in community groups who had never
attended school (10.4%) [3].
Diabetes distress (DD) is a psychological condition
which overlaps with anxiety, stress and depression [4].
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In 2005, Polonsky et al. published an assessment of psy-
chological distress in diabetes patients in three cities in
the U.S (San Diego, Boston, and Honolulu) [5]. Based on
that research, Polonsky et al. have developed the DD in-
strument labelled DDS (diabetes distress scale), focus-
sing on assessing DD in four domains: physician distress,
emotional burden, regimen distress, and interpersonal
distress [6]. In total, 28 items are covered in these 4 do-
mains. In 2012, Fisher et al. have conducted further re-
search to evaluate the association of the 28 DDS items
with the clinical condition of their participants [7]. Based
on the associations, the latest version of DDS could be
reduced to only 17 items [5, 7]. DD assessment is highly
recommended because it complements other T2DM as-
sessments, enabling a more comprehensive approach
both clinically as well as psychologically [6, 8].
Studies comparing DD scores across healthcare set-
tings are currently limited. We found two studies in the
Netherlands and Greece [9, 10], however, we have not
found any similar study for Indonesia. Both of these
studies reported that the DD scores of participants
treated in tertiary care were higher than those in primary
care. The Dutch study reported that besides the care set-
ting, other factors such as younger age, ethnic minority
status, use of insulin, higher HbA1c levels, higher body
mass index (BMI) and neuropathy were associated with
higher DD scores. Furthermore, the Greek study re-
ported that comorbidities, the use of insulin, and T2DM
duration were associated with higher DD scores.
This research is important to be carried out in
Indonesia because so far T2DM therapy is focused al-
most solely on the clinical aspects. It is important to
note that recent studies have proven that psychological
conditions of T2DM patients also highly influence levels
of glycemic control and overall well-being [10]. Further-
more, this research can be used as a scientific base for
the government of Indonesia in organizing T2DM pro-
grams, especially in supporting the government program
to strengthen the primary service in Indonesia. In this
study, we aimed to firstly compare DD scores in Indo-
nesian T2DM outpatients treated in primary care versus
those in tertiary care. Subsequently, we investigated
whether socio-demographic characteristics and clinical
conditions explain potential differences in DD scores
across healthcare settings.
Methods
T2DM management in Indonesia
In Indonesia, the national health insurance is known as
‘BPJS (Badan Penyelenggara Jaminan Sosial)/ Social Se-
curity Administrative Agency’. Since January 1st, 2014,
T2DM patients’ care in Indonesia has been managed by
a referral system, where all T2DM patients will receive
initial care in primary care (Puskesmas/ public
healthcare center (PHC)) and by a family doctor [11].
Determination of the location of primary care is based
on the location where the T2DM patients live, or by re-
quest of T2DM patients themselves [11]. At primary
care level, the BPJS also has a chronic disease manage-
ment program labelled Prolanis, which is an integrated
and tiered T2DM patient service program aimed at im-
proving the quality of life of T2DM patients in Indonesia
[12]. Besides BPJS’s Prolanis, another community-based
organization for T2DM patients exists, labelled Persadia
(Indonesian Diabetes Association) [13]. Prolanis and
Persadia both have the same goal. Therefore T2DM pa-
tients can follow the activities of both communities.
Research setting
Primary care
In our study, we defined primary care as the setting
where T2DM outpatients are managed by a GP. Gener-
ally and additionally, every 6 months they have an op-
portunity to consult with a resident of internal medicine
in a tertiary care facility (see below for exact definition).
Tertiary care
In tertiary care, T2DM outpatients are treated in a hos-
pital setting and monitored by a consulting resident of in-
ternal medicine. During the monitoring process, the
resident of internal medicine plans the therapy according
to guidelines, including the prescription of insulin for
T2DM outpatients whose blood glucose remains uncon-
trolled with oral antidiabetic drugs (OADs) therapy. Insu-
lin administration may continue for a certain period of
time until the patient shows better clinical outcomes, for
instance, his/her blood glucose is brought under control
(for example, fasting blood glucose (FBG) ≤126mg/dL)
and afterwards, therapy may be reverted from insulin to
OAD. Then, the consulting resident of internal medicine
refers the patients back to a primary care facility for con-
tinuing OAD therapy. However, there are also some
T2DM outpatients whose insulin therapy cannot be re-
placed by OAD, i.e. those who report OAD side effects or
are in continued need of insulin [14]. For this group of pa-
tients, therapy continues in tertiary care and they continue
to be monitored by a resident of internal medicine. In
areas with limited internal medicine facilities, T2DM out-
patients with insulin therapy can take routine examina-
tions in a primary care facility and get the insulin at
private pharmacies that collaborate with the BPJS.
Research context
Generally, health care facilities in primary and tertiary
care settings in Indonesia are public ones in which all
health service procedures are managed by the govern-
ment of Indonesia. In this research, all participants
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were covered with health insurance recommended by
the government.
Study design and research sites
A cross-sectional study was conducted between February
2015 and April 2016. The period of this study was deter-
mined by the health facility. Each researcher who was
going to collaborate with them would then be scheduled
so that in one period of data collection there would be
no more than one researcher (especially with topics and
methods of collecting data that were almost the same).
In primary care settings, participants were selected from
a family doctor in Wonosari in Yogyakarta, a PHC in
Surabaya (East Java) and a T2DM outpatients’ commu-
nity in Surakarta (Central Java). Data collection was
done every Friday and Saturday during a weekly patient
education program where T2DM outpatients gather for
weekly exercise and education about T2DM. In tertiary
care settings, participants were selected from RSUD
Kota Yogyakarta Hospital, PKU Muhammadiyah Hos-
pital in Yogyakarta, Moewardi Hospital in Surakarta
(Central Java) and BLUD RSUD Sekarwangi Hospital in
Sukabumi (West Java). Most of the participants were
interviewed in the waiting rooms of the hospitals while
they were waiting for a consultation with a consulting
resident of internal medicine. All the hospitals in this
study were public teaching hospitals. During their hand-
ling of T2DM patients, all the consulting residents were
under the supervision of an internist. The remaining
participants were questioned in the waiting rooms of the
hospitals’ pharmacies. The Medical Ethics Committee of
Universitas Gadjah Mada (Yogyakarta, Indonesia) ap-
proved the study with document number KE/FK/1188/
EC on November 12th, 2014 (the approval was amended
on March 16th, 2015 due to the increased number of
research sites). Furthermore, The Ministry of Home
Affairs of Republic of Indonesia issued a research recom-
mendation (number 440.02/ 4480 on 25 November
2014) and sent it to the provinces and regencies where
the proposed research was to be carried out. In addition,
we also obtained a research permit from the Central
BPJS with document number 856/ Bang/ 0914 on Sep-
tember 17, 2014. Based on this Central BPJS permit, we
were able to collaborate with BPJS branches in the prov-
inces and regencies. Data collection in all health facilities
obtained permission from relevant parties, such as hos-
pital directors, head of PHCs or family doctors.
Participants
We included outpatients with T2DM that were older
than 18 years. The participants of this study were only
those we met during data collection and were willing to
read and sign an informed consent and were comfort-
able with filling out the instrument. Some potential
participants refused to participate because: (i) they forgot
to bring their glasses; (ii) they felt too tired because of
the bureaucracy in the hospital, as some of them had
been in the hospital for around 7 h (since 5 am for regis-
tration). For participants with limited reading ability or
physical limitations, informed consent was given orally
by the caregiver (spouses or adult children) and they also
gave written consent with their caregiver as witnesses. In
this study, all caregivers were aged over 18 years.
Instrument
We used the Diabetes Distress Scale questionnaire in
Bahasa Indonesia (DDS17 Bahasa Indonesia) [15] to
measure the DD score. This instrument has been
through a translation process, revision and validation
into Indonesian language (see Additional files 1 and 2)
[15]. DDS17 Bahasa Indonesia consists of 17 items
which are divided into four domains. First, three items
are specified in the interpersonal distress domain con-
cerning items on support from family members and col-
leagues of T2DM outpatients. Second, five items specify
the emotional burden domain with regard to the con-
cerns and fears of T2DM outpatients concerning com-
plications. Third, four items in the physician distress
domain describe opinions of T2DM outpatients con-
cerning the knowledge and attitude of and the care pro-
vided by the treating physician. The last five items
specified in the regimen distress domain measure diffi-
culties of T2DM outpatients concerning the manage-
ment of T2DM therapies (including motivation) and
issues in self-confidence or stress, for example, caused
by routine blood sugar checks. Each item consists of a
scale ranging from 1 (not a problem) to 6 (a very serious
problem) [5]. The resulting sum score of the 17 items
would then range from 17, ‘not a problem’ to 102, ‘very
serious problem’ [5, 7]. According to the revised DDS
scores developed by Fisher et al. (2012) [7], an overall
mean score of less than 2.0 indicates little or no DD, a
score between 2.0–2.9 indicates moderate DD and a
score of 3.0 or higher indicates high DD.
Data collection procedure and data source
We collaborated with treating GPs and consulting resi-
dents of internal medicine to collect our data. The GPs
and residents assisted us by providing participants with
information about the research objectives, ethics and the
importance of participating. This information helped
participants to be more focused and comfortable and
strengthened the feeling that the research was supported
by the hospital staff. Participants were assisted by the re-
searcher or the research assistant while filling out the
questionnaire. We accompanied participants while the
instrument was filled out and gave them the opportunity
to ask questions. If necessary, information or explanation
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could be repeated to individual participants, so that all
participants have the same understanding of one item.
All the research assistants involved in this research got
training beforehand from the main researchers. In order
to minimize bias, one of the main researchers was always
present with the research assistants during the data col-
lection. Furthermore, the main researchers always dis-
cussed the data collection procedure before and after the
data collection. During the data collection process, the
same procedure was followed in the primary care and
tertiary care settings.
Socio-demographic characteristics such as age, sex, edu-
cational background, and occupation were collected using
the participants’ identity cards and from self-reporting. In
this study, the age of participants was classified into two
categories: younger/productive age (18–56 years) or retire-
ment age (> 56 years). Furthermore, those aged 18–56
years who reported not currently having a job were de-
fined as unemployed. Those who stated their main job is
to take care of the household were classified as house-
wives, even when they were beyond the retirement age.
Clinical condition such as the type of therapy, complica-
tions and other serious diseases were obtained from the
treating GPs and residents of internal medicine. Postpran-
dial blood glucose, FBG and T2DM duration were col-
lected from self-reporting. In this study, participants were
defined as having other serious diseases if they suffered
from other major diseases besides diabetes, such as cancer
or tuberculosis. Also, participants experiencing exclusive
T2DM complications, such as hypertension and cardio-
vascular diseases, were identified as a separate group.
Statistical analysis
Descriptive statistical analysis was performed to investi-
gate whether socio-demographic characteristics, variables
refelcting clinical conditions, and the DD score differed
between participants in primary and tertiary care. T-test
was performed to compare the normally distributed vari-
ables with the mean and standard deviation reported,
meanwhile Kruskal-Wallis rank sum tests were performed
to compare the variables with skewed distribution (i.e.,
non-normal) including DD scores with the median and
Table 1 Socio-demographic characteristics, clinical condition and diabetes distress scores of the participants in primary care compared
to those treated in tertiary care
Variables Primary care (n = 108) Tertiary care (n = 524) Overall (n = 632) P-value
Socio-demographic characteristics
Male sex 32% 44% 43% 0.235
Age [years]* 62 ± 9 60 ± 10 60 ± 10 0.010
University degree 12% 26% 26% 0.224
Occupation (I/II/III)a,*** 10%/40%/50% 31%/34%/35% 29%/35%/36% < 0.001
Accompanied by caregiver 53% 62% 61% 0.132
Clinical variables
Diabetes duration [years]* 5 (1–14); N = 31 4 (1–10); N = 312 5 (1–10); N = 343 0.028
Type of therapy (I/II/III/IV)b,*** 11%/67%/14%/8% 2%/57%/24%/17% 5%/59%/22%/14% < 0.001
Fasting blood glucose (FBG) [mg/dL] 130 (112–134); N = 9 140 (115–179); N = 249 140 (115–180); N = 258 0.440
Postprandial glucose [mg/dL] 167 (160–184); N = 9 192 (151–236); N = 234 190 (153–236); N = 243 0.603
Complications
No complication 47% 33% 32% 0.576
With one complication 33% 37% 36% 0.116
With two or more complications* 17% 23% 26% 0.011
With other serious diseases* 3% 7% 6% 0.011
Diabetes distress
Total score*** 28 (21–41) 21 (18–30) 23 (18–35) < 0.001
Emotional burden*** 8 (6–11) 6 (5–9) 7 (5–10) < 0.001
Physician distress*** 7 (5–10) 5 (4–7) 5 (4–8) < 0.001
Regimen distress*** 9 (6–13) 6 (5–9) 7 (5–11) < 0.001
Interpersonal distress*** 4 (3–6) 3 (3–5) 3 (3–6) < 0.001
Continuous variables are presented as mean ± standard deviation or median (interquartile range), and categorical variables are presented as percentages
aOccupation I, II, III respectively stand for active employee, unemployed, and housewife
bType of therapy I, II, III, IV respectively stand for Diet or no drugs, OAD, Insulin, Insulin+OAD
***P < 0.001;**P < 0.01;*P < 0.05
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inter-quartile range (IQR) reported. For the categorical
variables, the comparison were conducted based on Chi-
square test. Ordinal regression analysis was conducted with
the quartile of the summation of the DD scores categorized
based on its distribution as the dependent variable to inves-
tigate how the association between the level of healthcare
facilities and the DD score altered when adding different
confounding variables into the model. This model was
chosen because the distribution of the summation of DD
scores is highly skewed and as such a linear regression can-
not be performed with a non-normal response variable. A
generalized linear model, with ordinal regression as a spe-
cific type, was then conducted when the outcome variable
was not normally distributed (i.e., skewed). We assessed the
existence of multicollinearity in our model by the correl-
ation matrix of all independent variables (r > 0.80 indicates
multicollinearity) and the variance inflation factor (a value
> 10 indicates multicollinearity). The association between
the level of healthcare facilities and DD score was firstly in-
vestigated in an unadjusted model (model 1). Subsequently,
we investigated how such association altered when adjust-
ing for sex, age, educational level, occupation, and the pres-
ence or absence of a caregiver (model 2). We then
investigated the alteration by further adding the clinical var-
iables (T2DM duration, FBG) into model 2 (model 3). Fi-
nally, complications and other serious diseases were added
as variables into model 4 and model 5 (replacing the vari-
ables of clinical conditions in model 4 and a full model in
model 5). The differences in odds ratios between the
models (ΔOR) were subsequently calculated. In addition,
we investigated in each multivariate model (model 2 to 5)
how the socio-demographic characteristics and clinical vari-
ables independently related to the DD score except for the
effect of the level of care. We did not include the type of
therapy and postprandial glucose into any of our ordinal re-
gression models because adding these variables would
cause the resulting models deviating from the proportional
odds assumption [16]. Missing values on T2DM duration
and FBG were dealt with using multiple imputations [17].
For both the descriptive analysis and the regression model,
the complications and other serious diseases were described
as dichotomous data (i.e., yes/no one complication, yes/no
two or more complications, yes/no other serious diseases).
Considering the high percentage of missing measurements,
we obtained 50 imputed datasets for each measurement.
The completed measures were then computed by taking
the average values generated from each imputed dataset.
Statistical analyses were performed using R (R Foundation
for Statistical Computing, software version 3.4.0, Vienna,
Austria). The factors were considered statistically significant




In total, 632 participants were included in the study,
of whom 108 (17%) were from a primary care setting

















Primary care 2.91 (1.98–4.29)*** 3.39 (2.28–5.09)*** 3.48 (2.34–5.23)*** 3.61 (2.42–5.44)*** 3.68 (2.46–5.55)***
Socio-demographic characteristics
Male sex 1.01 (0.68–1.49) 1.03 (0.69–1.52) 0.98 (0.66–1.45) 1.01 (0.68–1.50)
Age [years] 0.97 (0.96–0.99)*** 0.98 (0.96–0.99)** 0.97 (0.96–0.99)*** 0.97 (0.96–0.99)**
University degree 1.40 (0.97–2.02) 1.40 (0.97–2.02) 1.38 (0.96–2.00) 1.37 (0.95–1.99)
Occupation (IIvs. I) 1.07 (0.72–1.58) 1.13 (0.76–1.67) 1.08 (0.73–1.60) 1.13 (0.76–1.68)
Occupation (III vs. I) 0.98 (0.62–1.56) 1.01 (0.64–1.61) 0.95 (0.60–1.51) 0.98 (0.62–1.57)
Accompanied by caregiver 1.58 (1.17–2.13)** 1.58 (1.17–2.14)** 1.55 (1.15–2.10)** 1.57 (1.16–2.12)**
Clinical condition
T2DM duration 0.98 (0.95–1.01) 0.98 (0.96–1.01)
Fasting blood glucose (FBG) 1.01 (1.00–1.01)** 1.01 (1.00–1.01)**
Complications
With one 1.24 (0.88–1.74) 1.22 (0.87–1.72)
With two or more 1.75 (1.19–2.59)** 1.73 (1.17–2.56)**
With other serious diseases 1.25 (0.67–2.32) 1.11 (0.59–2.08)
Occupation I, II, III respectively stand for active employee, unemployed, and housewife
***P < 0.001;**P < 0.01;*P < 0.05
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and 524 (83%) were from a secondary care setting
(Table 1). Participants in the primary care setting
were older and were relatively more frequently
housewives. In addition, they had a longer T2DM
duration and a lower percentage of suffering from
two or more complications and other serious dis-
eases. The total DD score in the primary care setting
was shown to be significantly higher than the score
in the secondary care setting. This was also the case
for the score in each domain.
Factors explaining differences in DD scores between
primary and tertiary care
Table 2 depicts the results of the ordinal regression
models. The multicollinearity statistics indicated no sig-
nificant multicollinearity between the independent vari-
ables. The unadjusted model (model 1) showed that the
level of health facilities was strongly associated with DD
(p < .001), with participants in primary care having a 2.91
times (95% CI 1.98–4.29) higher likelihood of being more
distressed than the participants in tertiary care. Model 2
showed that after adjusting for socio-demographic charac-
teristic variables, the association was strongly intensified
(ΔOR= 0.48). In Model 3, adding the clinical condition
variables further intensified the association between the
level of health facilities and DD (ΔOR= 0.09). In Model 4,
replacing clinical variables with complications showed a
moderately intensified association compared to model 2
(ΔOR= 0.22). The higher odds of experiencing DD in pri-
mary care compared with tertiary care remained signifi-
cant in the fully adjusted model (OR = 3.68, 95% CI 2.46–
5.55; p < .001). In addition to care setting, we found four
factors independently related to higher DD scores: youn-
ger age, participants with dependency on caregivers,
higher levels of FBG, and experiencing two or more
T2DM complications.
Discussion
Our study shows that participants treated in primary care
settings indicated more distress on the DDS17 than those
who were treated in tertiary care. In addition to the care
setting, we found four factors independently related to
higher DD scores: younger age, participants with depend-
ency on caregivers, higher levels of FBG, and experiencing
two or more T2DM complications. These results need to
be interpreted with caution as our data was collected
when the Indonesian government initiated a transform-
ation in the health insurance system. Previously, T2DM
outpatients were free to choose tertiary services (including
choosing a resident of internal medicine). However, the
new health insurance system has been further strength-
ened and referral to health facilities and these changes
could very well have an impact on DD.
The association between care setting and DD score was
substantially intensified after adjustment for the sociode-
mographic characteristics (ΔOR= 0.48). This finding is
not only attributable to the profound confounding effect
of the included factors on the association between the
level of healthcare and the DD score, it is also attributable
to the highly significant effect of age and dependency on
caregivers on the DD scores itself. Specifically, we found
that younger age is correlated with higher DD scores even
when controlling for the full set of variables (in model 5).
This finding is in line with the evidence from several other
studies. A comparable study in San Diego stated that the
higher DD score in the younger age group may be caused
by their family responsibilities, the financial challenges
and their daily work [18]. In addition, a study in Malaysia
stated that higher DD scores in younger participants were
not associated with a higher educational level, but
stemmed from the feeling that T2DM disrupted their daily
activities due to the therapy and self-management [19].
Furthermore, compared with the elderly, the younger age
group has less experience in managing T2DM, specifically,
in dealing with the unexpected T2DM diagnosis, therapy
and (fear of) complications [20].
We also found that participants with dependency on
caregivers had a higher DD score compared to those
who were unaccompanied. This finding is obvious to
some extent, as the participants dependent on a care-
giver were those with poorer health conditions and in
need of assistance in activities, such as the elderly or
participants with complications or other serious diseases.
In addition, most participants with low education stated
that they needed a caregiver to assist them during the
hospital administration process. In Indonesia, it takes at
least 7 h for the patient care process in the hospital start-
ing from registration, laboratory examination and doctor’s
consultation until the time they receive their medication
from the pharmacist [15]. A caregiver plays a role to help
the patients during their treatment in a healthcare facility.
Some elderly participants in our study stated that they al-
ways forget the physician’s explanation during the consult-
ation after they get back home, but with a caregiver
besides them during the consultation, they felt more se-
cure. Furthermore the caregiver could help them to re-
member the physician’s explanation and could assist in
collecting drugs in the pharmacy. Yet, this seems not
enough to offset the increased DD scores in this group.
The association between care setting and DD score
was slightly intensified after additional adjustment for
the factors with regard to the clinical condition (ΔOR =
0.09). This may be partly caused by the limited amount
of factors included in this group (i.e., only T2DM dur-
ation and FBG level) and the weak but significant effect
of the FBG level (OR = 1.01) on DD score. Two more
factors regarding clinical condition (type of therapy and
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postprandial glucose) were initially included in our re-
gression model. However, these two factors were not in-
cluded in the final models because with these variables
included the models no longer met the proportional
odds assumption, an important prerequisite to conduct-
ing the ordinal regression analysis in a more direct man-
ner [18]. The finding of the association between an
elevated FBG level and a higher DD score is in line with
other studies. A clinical trial in the U.S. reported that
higher levels of blood glucose were associated with
higher DD scores. Furthermore, in this U.S. study, it was
reported that controlled blood glucose had a positive im-
pact on mood, DD scores and HRQoL [21]. Besides, an-
other study conducted on Hispanic and non-Hispanic
patients in U.S also reported that lower DD scores were
associated with reductions in blood glucose levels [22].
From an analytical perspective, care has to be taken in
this study that due to the high percentage of missing
data on the FBG level (258 available evidence out of 632
participants), we used the multiple imputation approach
[17] to capture the FBG levels of the total sample. The
significant conclusion was then generated based on the
total sample instead of the 258 participants who had full
evidence of their FBG levels.
The association between care setting and DD score
was moderately intensified after additional adjustment
for the factors with regard to the complications and
other serious diseases (ΔOR = 0.22) within which having
two or more complications strongly increased the DD
score. This finding is in line with the Dutch study [9]
which reported a positive correlation with having differ-
ent kinds of complications and the increased Problem
Areas in Diabetes (PAID) scale. Furthermore, a study in
Indian patients also reported that T2DM complications
were a major predictor for high DD scores [23]. In our
study, 6% of the participants reported other serious dis-
eases (cancer, tuberculosis, gastritis, hepatitis and tu-
mors), resulting in higher DD scores. Research in Greece
also reported this positive association between comor-
bidities and higher DD scores [10].
People living with T2DM require a lifetime daily self-
management plan [24]. The changes in their daily life-
style and the disease may have a negative impact on
their psychological state and may contribute to DD. DD
refers to the fear of risk of T2DM complications, lack of
accessibility to high-quality healthcare facilities, worries
about self-management therapy and the perception of
lacking emotional support from family and colleagues [5,
7]. Four previous studies in U.S have found that indeed
higher DD scores, due to higher levels of distress, were
associated with worse psychological outcomes, poor self-
care, higher levels of haemoglobin A1c (HbA1c), lower
health-related quality of life (HRQoL) and increased
T2DM complications [5, 7, 8, 25]. Furthermore, periodic
DD assessments are important to facilitate early detec-
tion of DD and subsequent potential prevention of more
severe psychological disorders; notably, T2DM patients
with higher DD scores have been found to have an in-
creased risk of mortality [26]. Regular DD assessment
has been recommended by the IDF since 2012 [27].
The higher DD score in primary care found in our
study can be explained by several facility-based factors.
Recall that our data collection was performed in 2014,
during the time when the government of Indonesia
began to introduce the new health insurance system
transitioning from Askes to BPJS. One of the impacts of
this change is that the government strengthened the
tiered referral health service process. The health service
started from the primary care level, and T2DM outpa-
tients who had been undergoing their therapy at a ter-
tiary care had to be referred back to the primary care
(after approval by the internist who takes care of them).
In this study, during the data collection process, some of
the elderly participants shared their experiences that
since the transformation of the health insurance system,
they were confused by the complicated procedure and
bureaucracy of health care facilities. One of the impacts
was a change in the physician that prescribed them the
medical treatment. Often, they already felt comfortable
with the previous physician who treated them and the
change may have caused distress. In addition, some par-
ticipants argued that T2DM must be treated by special-
ists (as they had been doing), in other words they were
more confident in specialists’ knowledge. Last but not
least, some participants also revealed that the laboratory
facilities and the medicines at the tertiary care were
more complete than the primary care. To some partici-
pants, the type of medicine given by the internists was
better than the medicine they got from primary care.
Furthermore, as our data collection was conducted in a
public area under-reporting of participants’ experience
and psychological situation might have occurred due to
reluctance of being critical to the authorities. Notably, the
above selection criteria on age and willingness to partici-
pate were applied. To avoid further selection bias, no
other limitations on participation were applied. However,
it is important to also note that the specific sites chosen
and the type of outpatients that visit the sites did provide
a specific selection. Furthermore, during the data collec-
tion, the researcher explained to the participants that any
answer they provided would be kept private and confiden-
tial and an honest or subjective response would be helpful
in developing T2DM services in Indonesia.
Limitations of this study were that we were not able to
measure the HbA1c of the participants. This is because
not all health facilities are equipped with HbA1c testing
facilities. For some T2DM outpatients with good eco-
nomic circumstances, HbA1c testing were conducted in
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private laboratories. Also, there is a difference in policies
on HbA1c tests between different health facilities. As an
illustration, one particular PHC recommends only one
HbA1c tests per year and on the condition that the
T2DM outpatient is participating in activities organized
by that particular PHC, whereas Health Minister regula-
tion No.52 of 2016 [28] states that HbA1c tests should
be performed every 3 or 6 months. In addition, we also
had difficulties in collecting T2DM duration and FBG
levels, with only 40–50% of participants having the full
evidence. Furthermore, the number of participants in
tertiary care was nearly five times higher than in primary
care, as primary healthcare facilities seemed reluctant to
participate in the study. The unequal sample sizes be-
tween groups may influence the accuracy of the T-tests
in our descriptive comparisons presented in Table 1.
However, as most of the input parameters were not nor-
mally distributed and compared using the Kruskal-
Wallis test, and it was shown that the Kruskal-Wallis
test can be conducted with unequal group sizes [29], we
do not think this unequal sample size will influence the
statistical power of our model in general. Body mass
index was not measured in our study because during the
data collection procedure we were told by the partici-
pants that they felt uncomfortable about the measure-
ment since they felt too tired because of the bureaucracy
in the hospital. Some of them also felt uncomfortable if
we measured their weight and height in the hospital
waiting room. Another confounding factor, and com-
monly included in similar studies, is insulin use. We did
include this parameter in our descriptive table (Table 1)
under ‘type of therapy’. However, type of therapy was
not included as a confounder in the ordinal regression
model because the inclusion led the model deviating
from the proportional odds assumption [16], an assump-
tion that has to be met when using an ordinal regression
model in any analysis. Another limitation of this study
lies in the collection of clinical samples from our pa-
tients. Due to logistic and organizational challenges, not
all variables were available for all participants, which
limited the possibilities for correcting and adjusting the
results. The difference between DD scores in primary
care and tertiary care could have been better explained if
more confounding factors had been included compared
to the current inclusion in our regression models.
It is important to highlight that the majority of the
participants involved in this study were those who gen-
erally consistently followed the medication treatment,
were compliant and regularly visited the health care fa-
cilities to get T2DM medicines. We assume this condi-
tion is reflected in our research results, that no
participants are found with major DD. Further research
should be directed to complementarily analyse DD
scores in non-compliant and less controlled T2DM
patients. In addition to that, we assume if data collection
is done in several remote areas in Indonesia, transporta-
tion costs will be one of the main problems for them. As
an illustration, T2DM outpatients in one of the remote
areas (Mansalean village) in Central Sulawesi may spend
around USD$10 reaching a health facility.
This is the first study to present DD scores in Indonesia
but it is limited to Java. Participants from our study were
recruited from various healthcare providers such as family
doctors, the T2DM outpatient community, PHCs and
hospitals so that we assume that the results of the study
may provide an overall understanding of the state of DD
in Indonesia. Moreover, although the Indonesian popula-
tion is very heterogeneous, the Java population can be
regarded as quite representative as 57% of all Indonesians
reside in Java [30].
It can be implied from this research that serious con-
sideration should be given to conducting T2DM and DD
screening within the general context of Indonesian
healthcare [31]. Screening is in particular warranted as
the management of diabetes is continuously extending
and improving, potentially with future consideration of
DD being included. The risk of developing T2DM com-
plications can be lowered by population-based preven-
tion programmes (screening regularly for T2DM in
people at high risk). Obviously, the cost-effectiveness of
the approach should be analyzed. Meanwhile, identified
T2DM can be managed through several approaches,
such as treatment and/or advice following early detec-
tion and diagnosis to prevent rapid complications of
T2DM, providing easy access to integrative health facil-
ities including psychological services, essential medicine
and basic T2DM technologies [31]. Community support
also contributes positively to DD, for example, aiding
T2DM patients in accessing healthy food and sports fa-
cilities [32, 33], illustrating the need for aligned health
literacy programs for the patient and the environment,
such as the partners and other family members. We there-
fore recommend that besides improving access to good
health services for those with T2DM, primary care should
be comprehensively strengthened in terms of the manage-
ment of T2DM therapy. Furthermore, we recommend that
the Indonesian government should provide psychological
help and information in every healthcare facility to help
T2DM patients with DD, and inclusive empowerment in
the area of health literacy. Such psychological and infor-
mation services could be embedded within a number of
yet small-scale DM club activities (for example Prolanis
BPJS). Further (preferably cost-effective) upscaling of these
initiatives could be considered.
As one specific initiative, Prolanis concerns a chronic
diseases management program organized by the BPJS
that facilitates monthly visits between patients and a
physician or a consulting resident of internal medicine.
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In these visits, the patient’s blood glucose is examined,
followed by exercise and education about T2DM [34]. In
Prolanis activities, doctors could play a role in pro-
viding T2DM education and information, while psy-
chologists could provide psychological education to
reduce DD. Another specific recommendation is that
T2DM education should also be aimed at caregivers
or family members because they are the ones who
are able to monitor the developments of the therap-
ies given to the T2DM patients, the disease course
and the overall well-being. Such increasing awareness
and education will empower health literacy of both
the patients as well as the environment. It is likely
that increasing awareness and educating Indonesians
with T2DM not only about DM care but also about
the reforms in the health insurance system and
healthcare provision may be beneficial in reducing
DD. Currently, DD screening has not become a pri-
ority in Indonesia even under the recommendation
of the IDF [35] and American Diabetes Association
[36] as being a global guideline for T2DM. If screen-
ing for DM is undertaken, DD should be one of the
concerns of the Indonesian government. Addition-
ally, we also recommend gender-specific approaches
such as psychological consultations for female T2DM
patients, especially housewives. Finally, educating
T2DM outpatients about the reforms in the health
insurance system and healthcare provision as well as
engaging the family members in T2DM education
may be beneficial to reduce DD.
Conclusions
In this study, we found a higher DD score in Indonesian
T2DM outpatients from primary care compared to the pa-
tients managed in tertiary care. In addition to the care set-
tings, the following variables were found to be positively
related to a higher DD score: younger age, participants
with dependency on caregivers, higher levels of FBG, and
experiencing two or more T2DM complications. This is
the first study in Indonesia to compare DD scores within
different healthcare facilities. We recommend the general
consideration of DD by the government and of various pa-
tient characteristics. Our DD-estimates can fruitfully be
used in Indonesian healthcare policy making for T2DM
patients. Regular DD assessment with good data manage-
ment can be a reference for the government to determine
the intervention type which is suitable for each level of
health facility. For example, when there are more T2DM
patients with a high DD score in the regimen distress do-
main in a health care facility, T2DM education and train-
ing could be improved. If such actions are taken on the
knowledge gathered on DD, important further improve-
ments in diabetes care in Indonesia can be achieved.
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